Fluent

Fluent EBITDA per Share

Delisted

The EBITDA per Share of Fluent (TIUM.U.CN) as of Nov 5, 2026 is 0.11 USD. In the previous year, EBITDA per Share was 0.08 USD — a change of 40.26% (higher).

EBITDA per Share

0.11USD

YoY

40.26%

Last updated:

EBITDA per Share of Fluent is 2023 0.11 USD. EBITDA per Share of Fluent was 2022 0.08 USD. It decreases by 40.26% higher compared to the previous year.

The Fluent EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.00 USD
Jan 1, 2019
-0.18 USD
Jan 1, 2020
-0.10 USD
Jan 1, 2021
-0.04 USD
Jan 1, 2022
0.08 USD
Jan 1, 2023
0.11 USD
The Fluent EBITDA per Share history
YEAREBITDA per ShareYoY
0.11USD+40.26%
0.08USD-291.24%
-0.04USD-59.86%
-0.10USD-43.69%
-0.18USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

EBITDA per Share of Fluent is 0.11 USD in 2023.

EBITDA per Share of Fluent changed from 0.08 USD to 0.11 USD, representing a 40.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Fluent since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Fluent

All Key Metrics — Fluent